marketed as Avastin for the treatment of cancer, is not manufactured or licensed for use in the eye. A service using this product risks increasing the number of clinic visits and injections a ...

As Avastin needs to be removed from its original vials and introduced into single-use syringes suitable for injection into the eye, Novartis and Roche have long argued that the repackaging ...

An injection of Avastin stopped blood-vessel ... A Genentech spokesman said there's limited safety information about uses of Avastin in treating eye diseases. "We don't support or promote the ...

Genentech opposes the use of Avastin to treat eye diseases such as macular degeneration, noting that the drug isn't approved by regulators for this purpose. Genentech has a similar drug ...